Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Vitrolife

Vitrolife

Read in Swedish

Change in number of shares and votes in Vitrolife AB (publ)

08:30 / 30 July 2021 Vitrolife Press release

In accordance with the decision at the board meeting on 8 July 2021, Vitrolife AB has issued a total of 9,645,303 new shares. As of 30 July 2021, following the new issue of shares, the number of shares and votes in Vitrolife AB (publ) amounts to 118,195,878.

Gothenburg, July 30, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO

This disclosure contains information that Vitrolife AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on July 30, 2021 at 8.30 am CET.

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com.Website: www.vitrolife.com/

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/